Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. - Wikidata - awgldk - TriplyDB

Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.

Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.

http://www.wikidata.org/entity/Q43121712

about

Interventions for treating peripartum cardiomyopathy to improve outcomes for women and babies Peripartum Cardiomyopathy in Intensive Care Unit: An Update Principles of the prolactin/vasoinhibin axis Maternal cardiac metabolism in pregnancy Peripartum cardiomyopathy: current state of knowledge, new developments and future directions Heart failure in sub-Saharan Africa: review of the aetiology of heart failure and the role of point-of-care biomarker diagnostics Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology Sex differences in cardiovascular disease - Impact on care and outcomes.Peripartum cardiomyopathy: A puzzle closer to solution.Peripartum cardiomyopathy: challenges in diagnosis and management.Practical management of peripartum cardiomyopathy Sex and gender differences in myocarditis and dilated cardiomyopathy Peripartum cardiomyopathy: Euro Observational Research Program Peripartum cardiomyopathy: a current review.Sex- and gender-specific research priorities for the emergency management of heart failure and acute arrhythmia: proceedings from the 2014 Academic Emergency Medicine Consensus Conference Cardiovascular Research Workgroup.Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart.Acute and critically ill peripartum cardiomyopathy and 'bridge to' therapeutic options: a single center experience with intra-aortic balloon pump, extra corporeal membrane oxygenation and continuous-flow left ventricular assist devices Peripartum cardiomyopathy: current management and future perspectives Reversible Cardiomyopathies.Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD.Peripartum cardiomyopathy: a review.Bromocriptine as a new therapeutic agent for peripartum cardiomyopathy Myocardial recovery in peripartum cardiomyopathy: prospective comparison with recent onset cardiomyopathy in men and nonperipartum women.Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.Clinical characteristics and risk factors for peripartum cardiomyopathy.Peripartum cardiomyopathy: a contemporary review Molecular mechanisms of peripartum cardiomyopathy: A vascular/hormonal hypothesis.MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study.Heart failure in sub-Saharan Africa.Role of imaging in the detection of reversible cardiomyopathy.Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy Cardiomyopathies and myocardial disorders in Africa: present status and the way forward The 12-lead ECG in peripartum cardiomyopathy Peripartum cardiomyopathy: moving towards a more central role of genetics [The heart during pregnancy].Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy A Case of Breathlessness during Pregnancy: The Difficulty in Diagnosing Heart Failure.Could it be Quetiapine-induced Peripartum Cardiomyopathy?Article Commentary: Acute Heart Failure: Is it Peripartum Cardiomyopathy or Not?

P2860

Q24235585-C8F66A2A-5D4A-4F6F-8AA2-D56AC2E45B81 Q26774406-DAC1D13D-D7FA-4FC3-8B49-DF7C7514B9E5 Q26796671-1E48697A-36C9-4BE6-8A7E-4EE5C0926834 Q26865194-03EF65F9-8C9A-44ED-932D-C2EEA64D9321 Q27001962-60DD4E30-5E72-450B-836C-2D186F9899D1 Q27015261-EACB3360-C410-4A30-8E0C-C183D26117BA Q27024879-DD22A0FD-7866-4469-B43C-649211B62F1C Q30234726-E95F0C21-80A9-4D4A-BC35-AF2D69D02C23 Q33358118-5BDA7322-1B6F-4D3F-8C92-031E4C1CB7DE Q33363307-B8546B44-C055-45C4-B17E-3F3F096C64F9 Q33690735-6DB0B356-7770-4C21-9BC7-B30DE76DE965 Q34060039-D59D3ED8-D67D-41A1-85DB-40E4BC1D91BA Q34161231-9800722D-62DF-446F-A3BD-A0DF05990BCA Q34729767-5F83E24D-BC99-4E8A-B201-8AB3AFFA597A Q34836591-8F2DFF6B-0B59-4FFC-AB74-1F1312FB3088 Q34969073-96088A37-768C-407E-8BE4-0CA9AD53C632 Q35559442-0F7CBC24-A35A-4E53-B546-F541EFC7FA1F Q35578643-58A32B11-E8B2-45C8-9D99-AE1826C6E63B Q35636735-5D3B05D0-0F65-410F-B26B-CFD32DA40915 Q35758553-B064275D-34BC-4314-B949-F17239D5023C Q35820163-45130AC2-4BB9-4342-9EF7-053D98716991 Q35968131-2F4F9122-1710-4CFC-BA9E-A123F5C9F688 Q36170285-4BC89965-2B5D-4A54-8A5F-FAB58FF37DCE Q36214915-4910226C-4B91-40ED-83E1-73AC372F8E73 Q36292318-6C97FBC6-6C16-40A6-9082-25F9F19A3C85 Q36694091-4D220179-64C8-48D1-A83F-E4E8E5FA4DDE Q36701224-FE035E33-69D7-4260-B8EF-22BC764AD4AC Q36802746-1C8CA9D0-C44A-4022-A216-22C087B8F039 Q36853140-CF6648DD-6826-4CD4-9140-2DD268763C77 Q36928528-499A67CF-459F-4AEF-81AE-9E65E9ED851E Q36983228-A6ACF421-FAA0-43F7-8950-4CC5DFEBF4B8 Q37004855-EC504900-C848-4878-AB53-A0CC83E5ED7D Q37041843-11119DD4-E164-40F3-9482-83F9EC74EB14 Q37073321-315DACBD-1A5E-4230-8B50-47C6F1E322DB Q37190410-1029D826-51A5-469B-B09B-D1931F9E839B Q37242100-59935D08-C8DC-485C-8D0B-8822D6E21EA1 Q37250867-8913AD32-188D-4788-ADDF-FE6A07903E3F Q37315366-C14B5905-69D8-44FE-ACA7-D3AD3F56EB54 Q37315375-71907D95-7352-4D8E-B9D2-A1B94C8B5DE4 Q37315379-17C7D95D-AB3A-43CB-984D-1B067295753E

P2860

Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.

http://www.wikidata.org/entity/Q43121712

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Evaluation of bromocriptine in ...... proof-of-concept pilot study.

@en

Evaluation of bromocriptine in ...... proof-of-concept pilot study.

@nl

type

label

Evaluation of bromocriptine in ...... proof-of-concept pilot study.

@en

Evaluation of bromocriptine in ...... proof-of-concept pilot study.

@nl

prefLabel

Evaluation of bromocriptine in ...... proof-of-concept pilot study.

@en

Evaluation of bromocriptine in ...... proof-of-concept pilot study.

@nl

P1433

Q43121712-8911221F-89D5-4888-B243-2E6A30F85240

P1476

Q43121712-EF328814-97DA-4F06-9FC6-334428E81ABA

P2093

Q43121712-0DD8CC08-90FC-47A8-8511-9B68B737FD75

Q43121712-0E05AE4E-E66E-429D-BD11-C0063A7F939C

Q43121712-342FF2E3-ABA1-4311-A2A5-01CB53986F83

Q43121712-66CA21A1-BEFA-4B16-B078-8D3BBD22F621

Q43121712-A1C752C0-6FF9-4021-9525-4605DC301217

Q43121712-A8243788-FDAE-4A13-BF9E-64DF4DDDC00D

Q43121712-B26E217D-D0AF-4253-868B-E15466411C11

Q43121712-B8CA328B-F135-41AD-B509-22504313D2E0

Q43121712-BA0C4A0F-C5B7-4B71-B9AB-D2A323679E17

Q43121712-CA248BC8-07D1-4E17-9FA4-990FC44FD2B9

P304

Q43121712-F9E5FF82-C189-4C03-B605-2EFA0025887C

P31

Q43121712-D7D63310-B839-4F0F-BD1B-A39CD13ACF65

P356

Q43121712-3B13A370-E7D0-4AA3-91C9-71A681C9226A

P407

Q43121712-1D8867EB-B37D-4897-983C-9E92BB0EE572

P433

Q43121712-AD56EAE1-0F45-40F6-B3A9-5EFC0FB1AAB4

P478

Q43121712-E00A5A68-0863-46E6-B83D-226BCEBAC1C2

P50

Q43121712-09C05710-0063-419D-802C-76E7417A3C21

P577

Q43121712-AC0A5C3F-7AEF-4A34-9172-ACA482274BBA

P5875

Q43121712-9BCD6C84-1A24-485F-8A73-FBEDE6C93105

P698

Q43121712-E75FDC86-954E-4E5A-8F24-B186F18C626C

P356

CIRCULATIONAHA.109.901496

P1433

P1476

Evaluation of bromocriptine in ...... proof-of-concept pilot study.

@en

P2093

Anthony Becker

http://www.w3.org/2001/XMLSchema#string

Denise Hilfiker-Kleiner

http://www.w3.org/2001/XMLSchema#string

Elena Libhaber

http://www.w3.org/2001/XMLSchema#string

Hatice Yamac

http://www.w3.org/2001/XMLSchema#string

Ingrid Struman

http://www.w3.org/2001/XMLSchema#string

Jan-Peter Smedema

http://www.w3.org/2001/XMLSchema#string

Karen Sliwa

http://www.w3.org/2001/XMLSchema#string

Kemi Tibazarwa

http://www.w3.org/2001/XMLSchema#string

Lori Blauwet

http://www.w3.org/2001/XMLSchema#string

Saida Labidi

http://www.w3.org/2001/XMLSchema#string

P304

1465-1473

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.109.901496

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42389601

http://www.w3.org/2001/XMLSchema#string

P698

20308616

http://www.w3.org/2001/XMLSchema#string